KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gilead Sciences (GILD) Change in Inventory (2016 - 2026)

Gilead Sciences filings provide 17 years of Change in Inventory readings, the most recent being $123.0 million for Q4 2025.

  • On a quarterly basis, Change in Inventory fell 45.58% to $123.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.0 billion, a 143.19% increase, with the full-year FY2025 number at $1.0 billion, up 143.19% from a year prior.
  • Change in Inventory hit $123.0 million in Q4 2025 for Gilead Sciences, down from $515.0 million in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $515.0 million in Q3 2025 to a low of -$70.0 million in Q3 2021.
  • Median Change in Inventory over the past 5 years was $90.0 million (2022), compared with a mean of $130.2 million.
  • Biggest five-year swings in Change in Inventory: plummeted 369.23% in 2021 and later surged 2925.0% in 2023.
  • Gilead Sciences' Change in Inventory stood at -$35.0 million in 2021, then surged by 888.57% to $276.0 million in 2022, then increased by 11.23% to $307.0 million in 2023, then fell by 26.38% to $226.0 million in 2024, then plummeted by 45.58% to $123.0 million in 2025.
  • The last three reported values for Change in Inventory were $123.0 million (Q4 2025), $515.0 million (Q3 2025), and $175.0 million (Q2 2025) per Business Quant data.